AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

RecruitingNAAges 18 Years - 99 YearsAllUniversity Hospital, Toulouse
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Neurofeedback (NF) is a procedure for providing direct sensory feedback (in the form of visual, auditory or tactile stimulation) to a patient about their brain activity when performing a cognitive or motor task. This NF aims to allow the patient to become aware of this brain activity and thus learn to modulate it voluntarily in order to improve the performance obtained on the task. The aim of the study is to compare a "standard NF" procedure to a "personalized NF" procedure designed to optimize the level of patient acceptability based on the results obtained through these questionnaires.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Man, woman, over 18 years old * Motor deficit of the upper limb type of hemiplegia, secondary to a hemorrhagic or ischemic stroke authenticated by brain imaging (MRI or CT) * Post-stroke patients in the subacute phase, between 15 days and 6 months after the stroke * Correct or corrected vision allowing reading at a distance of 0 to 2m * Ability to maintain a seated position for 1 hour * Patient affiliated to a social security scheme or beneficiary of such a scheme * Informed patient having signed consent Exclusion Criteria: * Minors (age \< 18 years) * Phasic disorder limiting comprehension corresponding to a Boston Diagnostic Aphasia Examination (BDAE) score \< 4 * Attentional disorder not allowing sufficient attention to be maintained for 1 hour * History of known stroke with motor sequelae. * Known peripheral neurological pathology affecting the paretic upper limb. * Other known central neurological pathology * Factors hindering EEG acquisition (scalp pathology, abnormal cervico-cephalic movements, cranial metal implants) * Unstabilized epilepsy * Refusal to participate in the study * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, parturient, or breastfeeding patient
๐Ÿ’Š

What it tests

  • Neurofeedback procedure
  • Fugl-Meyer test
  • Intrinsic Motivation Inventory questionnaire
  • Hospital Anxiety and Depression Scale
  • State Anxiety Inventory scores
๐Ÿ“

Where

1 site
CHU de TOULOUSE
Toulouse, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy